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Epithelial–mesenchymal interactionSox9 encodes an HMG-domain transcription factor that is critically required in numerous developmental
processes such as chondrogenesis and otic placode formation. Here, we show that Sox9 is expressed in the
mesenchyme surrounding the developing cochlea in the mouse suggesting that Sox9 may also control
development of the otic ﬁbrocyte compartment and the surrounding otic capsule. Tissue-speciﬁc inactivation
of Sox9 in the periotic mesenchyme using a Tbx18Cre mouse line results in arrest of early chondrogenesis and
consequently, in a lack of cochlear otic capsule formation. Furthermore, loss of Sox9 severely compromises
expansion, differentiation and remodeling of the otic ﬁbrocyte compartment. Early cell proliferation defects
in the entire periotic mesenchyme of Sox9-deﬁcient inner ears suggest a cell-autonomous function of Sox9
for the development of the inner mesenchymal compartment. Abnormal cochlear duct morphogenesis in
Sox9mutants including disruption of the coiling process is tightly associated with the onset of mesenchymal
defects whereas the absence of major differentiation defects in the otic epithelium suggests that Sox9-
dependent mesenchymal signals primarily control epithelial morphogenesis.. Kispert).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The mammalian inner ear contains the sensory organs for hearing
and balance; the cochlea that perceives sound, and the vestibulum,
with utricle and saccule and semicircular canals that measures torsion
and linear acceleration. Unifying feature is the presence of specialized
sensory cells, the hair cells that transform mechanical deﬂection into
electrical signals, and forward them to associated neurons. Hair cells
are arranged in a continuous epithelial cell layer interspersed with
supporting cells that is surrounded by a layer of otic ﬁbrocytes
(termed inner compartment) and a protecting outer bony capsule
(reviewed in Raphael and Altschuler (2003)). Otic ﬁbrocytes do not
only serve as a mechanical link between the epithelial cell
compartment and the otic capsule but they are also critically involved
in the sensory process by maintaining the ionic homoeostasis
required for hair cell depolarization (reviewed in Wangemann
(2006)).
Epithelial and mesenchymal compartments of the inner ear arise
from distinct cell lineages during embryonic development. In themouse, a specialized region of the surface ectoderm adjacent to the
posterior hindbrain, the otic placode, starts to invaginate at E8.5 and
detaches to form a vesicle, the otocyst, around E10.0. Subsequent
epithelial morphogenesis generates the complex three-dimensional
(3-D) architecture of the vestibulum and the coiled cochlea. Cells of
the otocyst proliferate, migrate and differentiate to give rise to the
neurons of the cochleovestibular ganglion and the epithelial sensory
and non-sensory cells of the membraneous labyrinth (Kiernan et al.,
2002; Barald and Kelley, 2004, and references therein). Mesenchymal
cells of cranial paraxial mesodermal origin start to condense around
the otocyst at E10.0. The cells in direct proximity to the otic
epithelium will differentiate into otic ﬁbrocytes, whereas the outer
compartment of mesenchymal cells will undergo endochondral
ossiﬁcation to form the bony capsule that envelopes the membranous
labyrinth (Sher, 1971; McPhee and Van de Water, 1985; Cohen-
Salmon et al., 2000).
Tissue recombination and explant culture experiments in mice
and birds suggest that the regular development of epithelial and
mesenchymal compartments of the inner ear relies on intense
reciprocal tissue interactions (McPhee and Van de Water, 1986;
Swanson et al., 1990). In particular, factors inducing and regulating
chondrogenesis, including Fibroblast growth factors (Fgfs) 2,3 and
9, Transforming growth factor (Tgf)ß1 and Bone morphogenetic
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De Water, 1991; Frenz et al., 1994; Frenz and Liu, 1998; Liu et al.,
2003; Pirvola et al., 2004). Conversely, the periotic mesenchyme is a
source of signals that induce otic placode formation (Barald and
Kelley, 2004), and control patterning and differentiation of the
sensory epithelium (Montcouquiol and Kelley, 2003; Doetzlhofer et
al., 2004). Experimental removal of the periotic mesenchyme
decreases the morphogenetic potential of the epithelium indicating
that cellular reorganizations underlying the cochlear coiling mech-
anism require an interaction with the surrounding mesenchyme
(Miura et al., 2004). However, the in vivo relevance of these ﬁndings
and the nature of signaling factors and transcriptional circuits that
mediate and interpret tissue interactions during inner ear develop-
ment have remained elusive. Genetic analyses have recently
identiﬁed the POU domain, class 3, transcription factor 4 (Pou3f4)
and the T-box 1 protein (Tbx1) as potential regulators of these
processes. Loss of Pou3f4 in the periotic mesenchyme results in mild
defects of cochlear coiling morphogenesis (Minowa et al., 1999;
Phippard et al., 1999). In contrast, conditional inactivation of Tbx1, a
T-box transcription factor implicated in the etiology of DiGeorge
syndrome, from the periotic mesenchyme, results in a rudimentary
cochlea with severely compromised coiling and disrupted differen-
tiation of the Organ of Corti. These epithelial defects were
interpreted to be secondary to the disruption of pericochlear
capsule formation by decreased mesenchymal proliferation (Xu et
al., 2007).
Sox9 encodes a transcription factor with a conserved SRY-related
high mobility group (HMG) DNA binding domain (Foster et al., 1994;
Wagner et al., 1994). Sox9 is a critical regulator of chondrogenesis but
a requirement in the development of many other organs has also been
reported (Akiyama et al., 2002; for summary Kist (2009)). Homozy-
gous loss of Sox9 leads to early embryonic lethality (Akiyama et al.,
2004). Heterozygous mice die perinatally and serve as a model for
campomelic dysplasia, a human skeletal malformation syndrome that
is frequently associated with conductive and sensorineural hearing
loss (Tokita et al., 1979; Houston et al., 1983; Foster et al., 1994;
Wagner et al., 1994; Bi et al., 2001; Mansour et al., 2002).
In fact, studies in Xenopus and zebraﬁsh have previously provided
evidence for an additional primary function of Sox9 in inner ear
development. Morpholino antisense oligonucleotide-mediated deple-
tion of Sox9 protein in Xenopus embryos results in loss of early otic
markers and failure of otic vesicle development. Expression of an
inducible dominant negative version of Sox9 blocked otic develop-
ment during gastrulation, but had little effect on later inner ear
development, indicating that Sox9 is required for otic placode
speciﬁcation, but not for subsequent processes in otic development
(Saint-Germain et al., 2004). Furthermore, loss of Sox9a and Sox9b
function in zebraﬁsh results in the absence or severe reduction of the
otic vesicle (Yan et al., 2005), whereas over-expression of Sox9 in
Xenopus causes the formation of enlarged or ectopic otic vesicles
(Taylor and Labonne, 2005).
Tissue-speciﬁc Sox9 inactivation in the early otic epithelium
recently disproved a role in otic placode speciﬁcation in the mouse,
but suggested instead that Sox9 controls adhesive properties and
invagination of placodal cells in a cell-autonomous manner (Barrio-
nuevo et al., 2008). The early arrest of inner ear development in this
mouse model precludes investigation of an independent role of Sox9
in the periotic mesenchyme in which it is also expressed. Here, we use
a Tbx18Cre line to inactivate Sox9 speciﬁcally in the mesenchymal
compartment of the inner ear. We show that Sox9 is not required for
early condensation and compartmentalization of this tissue but for
formation of the cartilaginous otic capsule in the outer compartment.
Inactivation of Sox9 results in profound defects in expansion and
differentiation of otic ﬁbrocytes and cochlear duct morphogenesis
revealing crucial tissue interactions between mesenchymal and
epithelial compartments in the developing cochlea in vivo.Material and methods
Mouse lines and embryo preparation
For the generation of a Cre Knock-in allele of Tbx18 (Tbx18Cre,
Tbx18tm4(cre)Akis) a targeting vector was constructed to insert into the
Tbx18 locus a Cre ORF followed by a PGK-neo cassette ﬂanked by FRT
sites. After homologous recombination the ATG codon of Cre replaced
the endogenous Tbx18 start codon, and a 0.8 kbp genomic fragment
spanning from the ATG to a 3′-NotI site was deleted (Supplemental
Fig. 1). The targeting vector was conﬁrmed by restrictionmapping and
sequencing and linearized for electroporation into 129/SvImJ ES cells.
24 h after electroporation, selection of transgenic clones started by
addition of 125 µg/ml G418 to the medium. Surviving colonies were
expanded and genotyped by Southern blot similar to the generation of
LacZ and Gfp knock-in alleles of Tbx18 (Bussen et al., 2004; Wiese et
al., 2009). Two of ﬁve veriﬁed ES clones with a homologous
recombination event were microinjected into CD1 mouse morulae.
Chimeric males were obtained and mated to a FLPe deleter line (Tg
(ACTFLPe)9205Dym/J) (Rodriguez et al., 2000) to produce F1 animals
with the neo cassette removed. Tbx18Cre, Sox9ﬂox (Sox9tm1Gsr) (Kist et
al., 2002) and Rosa26LacZ (Gt(ROSA)26Sor) (Soriano, 1999) mice were
maintained on an NMRI outbred background. Embryos for Sox9
expression analysis were derived from matings of NMRI wild-type
mice. Tbx18Cre/+;Sox9ﬂox/ﬂox (Sox9KO) mice were obtained from
matings of Tbx18Cre/+;Sox9ﬂox/+ males and Sox9ﬂox/ﬂox females. Single
heterozygous littermates were used as controls for mutant embryos.
Tbx18Cre/+;Rosa26LacZ/LacZ mice were obtained from matings of
Tbx18Cre/+;R26LacZ/+ males and R26LacZ/LacZ females. For timed
pregnancies, vaginal plugs were checked in the morning after mating,
noon was taken as embryonic day (E) 0.5. Embryos were dissected in
phosphate-buffered saline (PBS) and ﬁxed in 4% paraformaldehyde
(PFA) in PBS. Genomic DNA prepared from yolk sacs or tail biopsies
was used for genotyping by PCR. AKO1110 sense primer (5′-
CAGATCTCGGGAGGCATCG-3′) and AKO1111 antisense primer (5′-
ATTCTCCCACCGTCAGTACG-3′) ampliﬁed a 723 bp fragment from the
Tbx18Cre allele. The oligos AKO0917/R1295 (5′-GCGAA-
GAGTTTGTCCTCAACC-3′), AKO0918/R523 (5′-GGAGCGGGAGAAATG-
GATATG-3′) and AKO0919/R26F2 (5′-AAAGTCGCTCTGAGTTGTTAT-
3′) were used in a multiplex PCR and ampliﬁed a 500 bp fragment
from the Rosa26wild-type allele and a 250 bp fragment from the LacZ
allele, respectively. AKO0745 (5′-CCGGCTGCTGGGAAAGTATATG-3′),
AKO0746 (5′-CGCTGGTATTCAGGGAGGTACA-3′), and AKO0747 (5′-
CTCCGGTAGCAAAGGCGTTTAG-3′) ampliﬁed a 247 bp fragment from
the Sox9wild-type allele and 419 bp/314 bp fragments from Sox9ﬂox/
Sox9del alleles.
Details on PCR conditions are available on request.
Histological analysis and 3-D reconstruction
Embryos were embedded in parafﬁn wax, sectioned to 5 or 10 µm
and stained with Hematoxylin and Eosin (5 µm) or Alcian blue and
Eosin (10 µm). For Alcian blue staining deparafﬁnized and rehydrated
sections were incubated for 30 min in freshly ﬁltrated Alcian blue
solution (pH2.5, 1 g Alcian Blue 8GX (Sigma) per 100 ml 3% acetic
acid), washed in PBS and counterstained with Eosin. 3-D reconstruc-
tions of Alcian blue stained serial sections were performed according
to published protocols (Soufan et al., 2003).
RNA in situ hybridization analysis
RNA in situ hybridization analysis on 10 µm parafﬁn sections was
performed following a standard procedure with digoxigenin-labeled
antisense riboprobes (Moorman et al., 2001). Probes used were as
follows: Aggrecan (NM_007424, Pos. 205–1167), Axin2 (Neidhardt et
al., 2000), Bmp4 (Jones et al., 1991), Bsnd (Birkenhager et al., 2001),
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Col2a1 (Cheah et al., 1991), Col9a1 (AK031071, Pos. 1420–3405), Cre
(X03453, Pos. 474–1518), Cx26 (NM_008125, Pos. 257–937), Dct
(Baxter and Pavan, 2003), LacZ (L08936, Pos. 3647–6691), Lfng (Zhang
and Gridley, 1998), Myo7a (AK052607, Pos. 1–2853), Otx2 (Simeone
et al., 1992), P27 (NM_009875, Pos. 646–1175), Pea3 (NM_008815,
Pos. 1–2336), Pds (Everett et al., 1999), Postn (AK30756 Pos. 1010–
3202), Pou3f4 (Minowa et al., 1999), Ptch1 (NM_008957, Pos. 1–
4305), Sox9 (Wertz and Herrmann, 2000), Rarb (NM_011243, approx.
Pos. 1–1675), Tbx1 (Hou et al., 2007), and Tbx18 (Kraus et al., 2001).
Immunohistochemistry
For the immunohistochemical detection of Sox9 protein on 5 µm
parafﬁn sections we used a polyclonal rabbit antiserum (a kind gift
from Gerd Scherer, Freiburg) in a dilution of 1:200 and kits from
Vector Laboratories (Vectastain ABC peroxidase kit (Rabbit IgG), DAB
substrate kit). Phosphorylated (P-)Smad proteins were detected on
5 µm parafﬁn sections using polyclonal rabbit-anti-P-Smad1/5/
8 (Cell Signalling, #9511, 1:100) and goat-anti-P-Smad2/3 (Santa
Cruz, sc-11769, 1:100) primary antibodies, biotin-SP-conjugated
secondary antibodies (Dianova, 111-065-003 and 705-065-003,
1:250) and the TSA Tetramethylrhodamine ampliﬁcation kit (Perki-
nElmer). Labeling with primary antibodies was performed at 4 °C
overnight after antigen retrieval (Sox9: 2 mM EDTA in 0.01 M Tris–
HCl, pH9, at 80 °C, 1 h; P-Smads: Antigen Unmasking Solution, Vector
Laboratories, 5 min pressure cooker), blocking of endogenous perox-
idases with 3% H2O2/PBS for 10 min and incubation in 2.5% normal
goat serum for 30 min in PBST (Sox9) or blocking buffer provided
from the TSA kit.
Cellular assays
Cell proliferation rates in tissues of E12.5 wild-type and Sox9KO
embryos (three each) were investigated by the detection of
incorporated BrdU on 5 µm parafﬁn sections according to published
protocols (Bussen et al., 2004). For each specimen ﬁve adjacent
sections of the basal or apical cochlear region, respectively, were
assessed. The BrdU-labeling index was deﬁned as the number of
BrdU-positive nuclei relative to the total number of nuclei as detected
by 4′,6-Diamidino-2-phenylindole (DAPI) counterstaining in arbi-
trarily deﬁned regions. Statistical analysis was performed using the
two-tailed Student's t-test. Data were expressed as mean±standard
deviation. Differences were considered signiﬁcant (*) when the P-
value was below 0.05, and highly signiﬁcant (**) when the P-value
was below 0.01. Apoptosis in tissues was assessed by TUNEL assay
using the ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit
(Chemicon) on 5 µm parafﬁn sections. All sections were counter-
stained with DAPI.
Documentation
Sections were photographed using a Leica DM5000 microscope
with a Leica DFC300FX digital camera. All images were processed in
Adobe Photoshop CS.
Results
Sox9 is expressed in the periotic mesenchyme of the developing inner ear
Previous analyses have demonstrated Sox9 expression in the
otocyst (Barrionuevo et al., 2008; Mak et al., 2009) and in the
mesenchymal compartment of the inner ear during selected stages of
mouse development (Kanzler et al., 1998; Trowe et al., 2008; Mak et
al., 2009). To provide a detailed Sox9 expression proﬁle during murine
inner ear development, we performed RNA in situ hybridizationanalysis on transverse and sagittal sections of mouse heads from the
onset of otic mesenchymal condensation to the beginning of otic
ﬁbrocyte differentiation (Fig. 1). No mesenchymal expression was
detected at E9.5 (data not shown). At E10.5, Sox9 expression was
strong in the ventro-lateral region of the mesenchyme surrounding
the otic vesicle, weaker in the medial aspect that extended into the
cranial mesenchyme, and absent dorsally (Fig. 1A). At E11.5, Sox9
transcript levels were consistently high throughout the periotic
mesenchyme (Fig. 1B), but at E12.5, Sox9 expression became
gradually restricted to the outer mesenchymal compartment that
gives rise to the otic capsule (Figs. 1C–D). From E15.5 onwards, Sox9
was down-regulated in this domain (data not shown) but expression
was newly initiated in the condensing mesenchymal cells of the
developing Stria vascularis and the spiral limbus that derive from the
inner periotic mesenchyme compartment (Figs. 1E and F). Hence,
Sox9 may play a role in the early condensation of the otic
mesenchyme, in chondrogenic differentiation of the outer mesenchy-
mal compartment and/or in the condensation of ﬁbrocytes that
underlie the developing Stria vascularis.
Conditional inactivation of Sox9 in the mesenchymal compartment of
the inner ear
Since Sox9-deﬁciency results in early embryonic lethality in mice
(Akiyama et al., 2004), we employed a tissue-speciﬁc inactivation
approach using a Tbx18Cre line generated in our laboratory to analyze
Sox9 function in the periotic mesenchyme. The T-box transcription
factor gene Tbx18 is transiently expressed in the paraxial head
mesoderm fromE8.0 to E10.5 (Kraus et al., 2001). From E12.5 to E18.5,
Tbx18 expression is restricted to periotic mesenchymal cells that lie
adjacent to the otic epithelium and will eventually differentiate into
otic ﬁbrocytes (Trowe et al., 2008). Reporter gene analysis using
ROSA26LacZ mice demonstrated that Cre expression from the Tbx18
locus mediates extensive recombination in the entire periotic
mesenchyme at E10.5 (Fig. 2B), and in mesenchymal precursor cells
of both the prospective inner (ﬁbrocyte) and outer (capsule)
compartments at E14.5 (Fig. 2D). Thus, despite restricted expression
of Tbx18/Cre in the inner compartment of the otic mesenchyme
(Figs. 2A and C), widespread expression of Tbx18 in the early cranial
paraxial mesoderm, results in Tbx18Cremediated recombination in the
entire periotic mesenchyme.
Tbx18Cre/+;Sox9ﬂox/ﬂox (Sox9KO) mice were born in a normal
Mendelian ratio, but died shortly after birth for unknown reasons.
The absence of Sox9mRNA expression and dramatic reduction of Sox9
positive cells in the periotic mesenchyme of the cochlea in Sox9KO
embryos at E10.5 and the absence of both mRNA and protein at E12.5
substantiate the suitability of this genetic approach to analyze Sox9
function in the cochlea of the inner ear (Figs. 2E–H, Supplemental
Fig. 2). Due to incomplete recombination in the vestibular (dorsal)
portion of the inner ear (arrows in Fig. 2H), the phenotypic alterations
in this compartment were not further analyzed.
Otic capsule differentiation and cochlear duct coiling are severely
disrupted in inner ears of Sox9KO embryos
Histological analysis of Sox9KO inner ears at E18.5 indicated
dramatic morphological abnormalities of the cochlea affecting both
the mesenchymal cell compartment in which Sox9 was speciﬁcally
inactivated and the epithelium of the cochlear duct (Figs. 3A–D). The
total space occupied by otic tissue was severely reduced, whereas the
loose connective tissue surrounding the Eustachian tube was
expanded (Fig. 3B, asterisk). The Scala mediawas normally developed,
however, the Scala vestibuli remained rudimentary and the Scala
tympani did not form at all (Fig. 3B). The mesenchyme between the
epithelium of the cochlear duct and the branch of the internal carotid
artery, i.e. the prospective mesenchyme of the lateral wall, appeared
Fig. 1. Sox9 is dynamically expressed in mesenchymal cells of the developing inner ear. (A–F) RNA in situ hybridization analysis of Sox9 expression during cochlea development on
transverse (A–C,E,F) and sagittal (D) sections of wild-type mouse heads. Arrow in A marks a Sox9 negative domain dorsal of the otocyst. Arrowhead in C marks exclusion from the
inner region of the periotic mesenchyme. Section plane of D is indicated in C. cd, cochlear duct; hb, hindbrain; l, lateral; nt, neural tube; otc, otic capsule; ov, otic vesicle; pom, periotic
mesenchyme; p, posterior; sg, spiral ganglion; sl, spiral ligament; slb, spiral limbus; sm, Scala media; st, Scala tympani; stv, Stria vascularis; sv, Scala vestibuli; v, ventral.
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(Fig. 3D). In contrast, larger, round cells of the spiral limbus were
clearly distinguishable from the surrounding connective tissue
(Fig. 3D), indicating that Sox9 is required for the normal development
of the lateral wall but dispensable for the differentiation of otic
ﬁbrocytes in the central cochlear region.
Most of the cartilaginous otic capsule tissue was absent in the
cochlear region (Fig. 3B) of Sox9KO mice at E18.5, a ﬁnding that was
conﬁrmed by Alcian blue staining of deposited cartilaginous extra-
cellular matrix (ECM) (Fig. 3F). The otic capsule of the vestibular
region appeared partially reduced (arrowheads in Figs. 3F and H)
compatible with the ﬁnding of incomplete Cre-mediated Sox9
inactivation in the dorsal portion of the otic mesenchyme (Fig. 2B).
We also noted a severe alteration of cochlear duct coiling in Sox9KO
embryos (Fig. 3B). Although the basal turn was present, visualization
of cochlear duct morphology by 3D-reconstruction from serial
histological sections revealed an irregularly shaped structure featur-
ing 1.0 instead of 1.7 turns. In addition, the apex of the cochlear duct
was oriented dorsally rather than in its normal ventral direction
(Figs. 3H, J and L). These results show that loss of Sox9 expression in
the periotic mesenchyme impairs the correct formation of the otic
capsule, affects the otic ﬁbrocyte compartment, and surprisingly,
disrupts morphogenesis of the cochlear duct.
Minor gene expression changes in Sox9KO cochlear ducts indicate
normal patterning and differentiation of the otic epithelium
Loss of mesenchymal Sox9 expression might not only alter the
morphology but also affect differentiation of the otic epithelium. Adetailed histological examination of the deformed cochlear duct
revealed the presence of epithelial sub-compartments including
Reissner's membrane, lateral wall and sensory epithelium (Figs. 4A
and B). Molecular characterization of the differentiation status of
epithelial cells by RNA in situ hybridization analysis at E18.5
conﬁrmed and extended these histological ﬁndings (Figs. 4C–O).
The homeobox transcription factor gene orthodenticle homolog 2
(Otx2) was normally expressed in Reissner's membrane of wild-type
and Sox9KO inner ears (Figs. 4C and D) (Morsli et al., 1999).
Expression of the Bartter syndrome, infantile, with sensorineural
deafness gene (Bsnd), that encodes a chloride channel subunit, in
the adjacent lateral wall indicated normal differentiation of marginal
cells of the Stria vascularis in Sox9KO embryos (Figs. 4E and F)
(Birkenhager et al., 2001; Estevez et al., 2001). Pds, encoding the ion
transporter solute carrier family 26 member 4, Slc26a4, is expressed
in epithelial cells of the outer sulcus (Everett et al., 1999). In the Sox9
mutant, the spatial context of Pds expression between the Stria
vascularis (Bsnd-positive) and the supporting cells (P27-positive) was
maintained but the domain was signiﬁcantly reduced in size. In
addition, ectopic expression of Pdswas found at the base of Reissner's
membrane adjacent to interdental cells (Fig. 4H, white arrow).
Expression of P27 (also known as cyclin-dependent kinase inhibitor
1B, Cdkn1b) that marks the supporting cells of the pro-sensory
epithelium (Chen and Segil, 1999), of Bmp4 in Hensen and Claudius
cells (Morsli et al., 1998) and of myosin VIIA (Myo7a) in outer and
inner hair cells (Hasson et al., 1995) was unchanged (Figs. 4I–N),
indicating normal differentiation of other sub-regions of the otic
epithelium. In conditional Tbx1-mutant mice a loss of hair cells was
found in the apical region of the cochlear duct (Xu et al., 2007).
Fig. 2. Conditional inactivation of Sox9 in the periotic mesenchyme of the developing cochlea. RNA in situ hybridization analysis of Cre (A,C) and LacZ (B,D) expression on transverse
sections through the head of Tbx18Cre/+;Rosa26LacZ/+-embryos (A–D). Sox9 immunostaining in Tbx18Cre/+;Sox9ﬂox/ﬂox (Sox9KO) and control embryos (E–H). Stages and genotypes
are as indicated. Due to early expression of Tbx18 in the head mesenchyme, Tbx18Cre-mediated recombination already occurs at E10.5, preceding the onset of periotic mesenchymal
expression of Tbx18 and Cre (arrows in A,B), and comprises all cells of the periotic mesenchyme, i.e. the precursors of the otic capsule and otic ﬁbrocytes. White arrow (F) indicates
few remaining Sox9-positive cells in the ventral periotic mesenchyme of Sox9KO embryos. Arrows and arrowheads (H) indicate loss of Sox9 expression in the vestibular and cochlear
portion of the inner ear in Sox9KO embryos. cd, cochlear duct; hb, hindbrain; l, lateral; nt, neural tube; of, otic ﬁbrocytes; otc, otic capsule; ov, otic vesicle; pom, periotic mesenchyme;
p, posterior; v, ventral.
Fig. 3. Abnormal otic capsule differentiation and cochlear coiling in Sox9KO embryos at E18.5. (A–D) Hematoxylin and Eosin staining of sagittal cochlea sections. Asterisk (*) marks
loose connective tissue surrounding the Eustachian tube (B). Basal coil of the cochlea (C,D). Arrow indicates condensed mesenchyme of the lateral wall (D). (E,F) Alcian blue staining
of cochlear cartilage on transverse sections of heads. (G–L) 3-D reconstruction of the cochlear duct and the otic capsule in frontal views (G,H), and of the cochlear duct in a
perspective parallel (I,J) and perpendicular (K,L) to the central cochlear axis. Genotypes are as indicated. Arrow (F) marks the expansion of the otic capsule in the basal part of the
cochlea. Arrowheads (F,H) indicate disturbed otic capsule formation in the vestibular portion of the inner ear. Arrowheads (L) indicate the apex of the cochlear duct. aci, branch of the
Arteria carotis interna; cd, cochlear duct; et, Eustachian tube; l, lateral; otc, otic capsule; p, posterior; sl, spiral ligament; slb, Spiral limbus; sm, Scala media; st, Scala tympani; sv, Scala
vestibuli; v, ventral.
55M.-O. Trowe et al. / Developmental Biology 342 (2010) 51–62
Fig. 4.Minor epithelial patterning defects in the Sox9KO cochlea at E18.5. Hematoxylin and Eosin staining (A,B), and analysis of marker gene expression by RNA in situ hybridization
(C–N) on sagittal sections of the cochlea of control and Sox9KO embryos. Figures show the basal coil of the cochlea. Probes and genotypes are as indicated in the ﬁgure. (A,B)
Arrowheads mark sensory cells, black arrows indicate the boundary between the epithelium of the lateral wall and sensory region, and asterisks mark the extent of Reissner's
membrane. (H) White arrow marks an ectopic Pds expression domain. (O) Schematic summary of epithelial differentiation in Sox9KO cochleae. cc, Claudius cells; hc, Hensen cells;
idc, interdental cells; ihc, inner hair cells; lw, lateral wall;. mc, marginal cells; ohc, outer hair cells; os, outer sulcus; rm, Reissner's membrane; sc, supporting cells; se, sensory
epithelium.
56 M.-O. Trowe et al. / Developmental Biology 342 (2010) 51–62However, normal expression of P27 andMyo7aA in the apical region of
the cochlear duct showed that these cells are present in Sox9KO
embryos (Supplemental Fig. 3).
Thus, Sox9 and Sox9-dependent processes in the periotic mesen-
chyme are not essential for the patterning of the cochlear duct but are
rather required to ﬁne-tune epithelial differentiation (Fig. 4O).
Differentiation of the periotic mesenchyme is impaired in Sox9-deﬁcient
inner ears
Histological analysis of Sox9-deﬁcient inner ears had revealed an
expansion of loose connective tissue at the expense of the otic
capsule and otic ﬁbrocytes (Fig. 3B). We used RNA in situ
hybridization analysis of marker genes to further assess compart-
mentalization and differentiation of the periotic mesenchyme in
Sox9KO embryos at E18.5 (Fig. 5). Otic ﬁbrocyte markers Pou3f4 and
Tbx18were expressed in a thin seam of mesenchyme adjacent to the
cochlear duct indicating a lack of mesenchymal expansion (Figs. 5B
and D). Expression of the Car3 gene, that encodes carbonic
anhydrase III, was conﬁned to spiral ligament ﬁbrocytes in wild-
type but was absent in Sox9KO embryos suggesting mis-differenti-
ation of Tbx18/Pou3f4 positive otic ﬁbrocytes in this region (Figs. 5E
and F). Expression of the coagulation factor C homolog (Coch), which
is restricted to the spiral limbus and a proximal region of the otic
mesenchyme underlying the epithelium of the lateral wall in thewild-type at this stage, was only present in the spiral limbus region
of themutant (Figs. 5G and H). Expression of Connexin26 (Cx26), also
known as gap junction protein, beta 2 (Gjb2) and of E-Cadherin,
normally restricted to condensingmesenchymal cells underlying the
Stria vascularis, was absent from the periotic mesenchyme of Sox9KO
embryos (Figs. 5I and J and data not shown). Collectively, these
ﬁndings argue that otic ﬁbrocytes of the lateral wall fail to
differentiate whereas properties of spiral limbus ﬁbrocytes are still
maintained in the Sox9KO inner ear.
Expression of the dopachrome tautomerase gene (Dct) that marks
intermediate cell precursors of the Stria vascularis (Steel et al., 1992)
appeared unchanged in the mutant indicating that migration of
neural crest cells from which these cells derive occurred normally
(Fig. 5L). Notably, we found loss of Col2a1 and ectopic expression of
Periostin (Postn) in the outer mesenchymal compartment of the
Sox9KO cochlea indicating that otic capsule was replaced by ﬁbrous
connective tissue (Figs. 5N and P). Col2a1 expression was main-
tained in the mesenchymal seam adjacent to the epithelium
conﬁrming a heterogeneous architecture of the periotic mesen-
chyme in the mutant with Sox9-independence of Col2a1 expression
in this region (Fig. 5N). Together, these results show that loss of
mesenchymal Sox9 expression leads to impaired growth and
differentiation of the periotic mesenchyme into ﬁbrocytes and
capsule tissue and to abnormal formation of the mesenchymal
cavities (Fig. 5R).
Fig. 5. Impaired expansion and differentiation of the periotic mesenchyme in Sox9KO embryos at E18.5. (A–P) Analyses of marker gene expression by RNA in situ hybridization with
probes as indicated on sagittal sections of E18.5 cochleae of control and Sox9KO embryos. Dashed lines (N,P) mark the boundary of the outer otic mesenchyme and the branch of the
A. carotis interna, respectively. White arrowhead in N indicates loss of Col2a1 expression in the outer periotic mesenchyme compartment. (R) Schematic summary of mesenchymal
differentiation in the Sox9KO cochlea. a, anterior; aci, branch of the A. carotis interna; cd, cochlear duct; otc, otic capsule; sl, spiral ligament; slb, Spiral limbus; sm, Scala media; st,
Scala tympani; stv, Stria vascularis; sv, Scala vestibuli; v, ventral.
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the otic mesenchyme but not the initial condensation and patterning of
this tissue
Sox9 is strongly expressed throughout the periotic mesenchyme,
before expression is gradually restricted to the outer compartment
that gives rise to the otic capsule at E12.5. We therefore wondered
whether the observed mesenchymal differentiation defects might be
caused, or at least be affected, by a failure in early recruitment and
condensation, and/or the compartmentalization of the periotic
mesenchyme.
Histological analysis of the E11.5 Sox9KO cochlea showed a normal
outgrowth of the cochlear duct but the surrounding periotic
mesenchyme appeared less condensed (Figs. 6A and B). Expression
of Col2a1 and collagen type IX, alpha 1 (Col9a1) that encode ECM
proteins mainly present in chondrogenic tissues and cartilage, was
absent (Col2a1) or strongly reduced (Col9a1), respectively, in the
cochlear periotic mesenchyme (Figs. 6C and D, data not shown).
Expression of Tbx1 was reduced in the ventral periotic mesenchyme(Figs. 6E, F, arrow). Histological analysis of mutant cochlea at E12.5
revealed a thickened otic epithelium with increased diameter of the
cochlear duct and a reduction of the surrounding periotic mesen-
chyme. However, the otic mesenchyme showed normal condensation
and subdivision into an inner and outer compartment with low and
high cell density, respectively (Figs. 6G and H). Compartmentalization
of the Pou3f4-positive periotic mesenchyme was conﬁrmed by
restriction of Tbx18 expression to the inner compartment in Sox9
mutants (Figs. 6I and L). Expression of Col2a1 and Col9a1 was absent
in the outer and reduced in the inner compartment of the periotic
mesenchyme (Figs. 6M–P). Expression of Tbx1 that is co-expressed
with Sox9 in the outer compartment at this stage was strongly down-
regulated in Sox9KO embryos (Figs. 6Q and R).
At E13.5, i.e. at the onset of chondrocyte differentiation in the outer
ring of the periotic mesenchyme, deposition of cartilagenous
proteoglycans as assessed by Alcian blue staining was already
diminished in Sox9KO embryos (Figs. 6S and T). At E15.5, Sox9KO
embryos exhibited a rudimentary developed cartilagenous otic
capsule in the cochlear region (Figs. 6U and V).
Fig. 6.Normal condensation and patterning of the periotic mesenchyme in Sox9KO inner ears. Hematoxylin and Eosin staining (A,B,G,H) andmarker gene expression analysis by RNA
in situ hybridization (C–F,I–R) on transversal sections of E11.5 cochleae (A–F) and sagittal sections of E12.5 cochleae (G–R) of control and Sox9KO embryos with probes as indicated.
Arrow in F indicates downregulation of Tbx1 expression. (S–V) Histological detection of cochlear cartilage by Alcian blue staining on transverse sections of heads. (W–Z) 3-D
reconstruction of the cochlear duct in a perspective parallel to the central cochlear axis. Stages and genotypes are as indicated. cd, cochlear duct; hb, hindbrain; l, lateral; otc, otic
capsule; pom, periotic mesenchyme; p, posterior; sg, spiral ganglion; v, ventral.
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condensation and compartmentalization of the periotic mesenchyme.
However, Sox9 is required for recruitment and/or expansion of these
cells, and chondrocyte differentiation in the outer mesenchymal
compartment.
Broadeningof the cochlear duct increased after E12.5 (Figs. 6S andT),
and from E13.5 onwards coiling morphogenesis was severely
impaired in Sox9 mutants (Figs. 6W–Z), arguing that epithelial
defects are not a late consequence of Sox9-deﬁciency in the periotic
mesenchyme but are closely associated with the early mesenchymal
changes.
Sox9 regulates cell proliferation in the periotic mesenchyme and in the
epithelium of the cochlear duct
Abnormal coiling morphogenesis of the cochlea and reduced
expansion of mesenchymal compartments in the inner ear of Sox9
mutants suggested impaired cell proliferation and/or apoptosis of
precursor cells. Indeed, we observed an overall size reduction of the
cochlea at E12.5 (Fig. 3B). We assessed the relative proliferation of
mesenchymal and epithelial compartments in Sox9KO inner ears at
this stage, i.e. prior to the manifestation of the severe morphological
abnormalities. For this analysis, we deﬁned two mesenchymal
domains at the apical region of the cochlear duct and three epithelial
regions (basal, medial and apical) that were further subdivided intopro-sensory and non-sensory areas (Figs. 7A–D). The overall
proliferation rate in the periotic mesenchyme of Sox9KO embryos
was decreased by 32%. In the pro-sensory epithelium we found a
reduction of 22% (basal) and 51% (medial), respectively. In the apical,
non-sensory epithelium, we detected a 43% increase in proliferation
(Fig. 7E). Assessment of apoptosis by the TUNEL assay, in contrast, did
not reveal any alterations in cell survival at this stage (Figs. 7F and G).
We conclude that Sox9 is involved in proliferation control and the
proper expansion of the early mesenchymal compartment. Moreover,
the results show a Sox9-dependent role of the periotic mesenchyme in
controlling the proliferation rate of the epithelial cochlear duct cells.
In an attempt to further understand the molecular and cellular
mechanisms underlying the morphological defects of the otic
epithelium in Sox9KO embryos, we analyzed the activity of a number
of signaling pathways known to play important roles in mesenchy-
mal–epithelial tissue interactions. For Wnt/ß-Catenin-signaling we
screened for expression of the universal target gene Axin2 (Jho et al.,
2002) by in situ hybridization analysis on sections of E11.5 and E12.5
Sox9KO inner ears. Similarly, we analyzed expression of patched
homolog 1 (Ptch1) for Hedgehog-, retinoic acid receptor beta (Rarb) for
retinoic acid- and ets variant gene 4 (Etbv4, Pea3) for Fgf-signaling
(Goodrich et al., 1996; Rossant et al., 1991; Tsou et al., 1994; Hayashi
et al., 2008). To investigate a role of Bmp- and TGFß-signaling, we
analyzed the expression of the intracellular mediators Phospho-
Smad1/5/8 and Phospho-Smad2/3 (Miyazawa et al., 2002) by
Fig. 7. Deregulated cell proliferation in the cochlear duct epithelium and the periotic mesenchyme of Sox9KO embryos. (A–D) Analysis of cell proliferation by the BrdU-incorporation
assay on transverse sections of the inner ear at the apical (A,B) and basal to medial (C,D) region of the cochlear duct. Assessed regions are numbered (periotic mesenchyme adjacent
to the pro-sensory/non-sensory epithelium (1/2); pro-sensory/non-sensory epithelium in the apical (3/4), medial (5/6) and basal (7/8) part of the cochlear duct). (E)
Quantiﬁcation of cell proliferation by the BrdU-labeling index. Error bars indicate the standard deviation. Signiﬁcant values as calculated by two-tailed Student's t-test are marked by
one (Pb0.05) or two asterisks (Pb0.01), respectively. In Sox9KO embryos, proliferation in the periotic mesenchyme is reduced. Epithelial proliferation is decreased in the basal and
medial pro-sensory, and increased in the apical non-sensory cochlear duct. (control vs. mutant, (1): 0.384±0.014 vs. 0.261±0.018; (2):0.384±0.059 vs. 0.256±0.021; (3): 0.107
±0.031 vs. 0.065±0.019; (4): 0.204±0.036 vs. 0.292±0.014; (5): 0.218±0.018 vs. 0.107±0.015; (6):0.141±0.065 vs. 0.236±0.081; (7): 0.434±0.46 vs. 0.337±0.020; (8):
0.134±0.036 vs. 0.170±0.048; n=3). (F,G) Analysis of cell death by the TUNEL assay on sagittal sections of E12.5 embryos. Nuclei are counterstained with DAPI. cd, cochlear duct; l,
lateral; pom, periotic mesenchyme; p, posterior; sg, spiral ganglion; v, ventral.
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of Phospho-Smad1/5/8 and Phospho-Smad2/3 were not changed in
the otic epithelium of Sox9KO inner ears at these stages suggesting
that neither canonical Wnt nor Hedgehog, retinoic acid, Fgf, Bmp or
Tgfß signals act downstream of Sox9 in the otic mesenchyme to
control cochlea morphogenesis (Supplemental Fig. 4).
Discussion
The genetic pathways that regulate the differentiation of the
periotic mesenchyme in the inner ear and coordinate mesenchymal
development with that of the epithelial cochlear duct have been
poorly deﬁned. This study demonstrates that Sox9 is a key factor in
regulating differentiation and expansion of otic ﬁbrocytes, formation
of the endochondral capsule and cochlear duct coiling. Whereas the
ﬁrst two processes are likely to reﬂect a cell-autonomous requirement
for Sox9, the latter provides evidence for the necessity of the
mesenchymal inner ear compartment for normal morphogenesis of
the otic epithelium.
Sox9 regulates otic capsule formation
Development of the otic capsule occurs by endochondral ossiﬁca-
tion, i.e. a mesenchymal matrix gives rise to a cartilaginous template
that is subsequently replaced by bone tissue (Sher, 1971). Chondro-
genesis progresses through distinct cellular programs including cell
sorting, aggregation and compaction of mesenchymal progenitors
followed by overt chondrocyte differentiation (Hall and Miyake,
2000). Inactivation of Sox9 in developing limb mesenchyme leads to
complete loss of the cartilagenous pre-skeleton deﬁning this
transcription factor as an essential regulator of chondrogenesis(Akiyama et al., 2002). In vitro studies have shown that Sox9 is not
required for initial formation of mesenchymal cell condensations but
for their maintenance and subsequent chondrocyte differentiation (Bi
et al., 1999; Barna and Niswander, 2007; Hargus et al., 2008). Our
ﬁnding that compaction of mesenchymal cells in the outer compart-
ment of the periotic mesenchyme occurs in Sox9KO embryos but that
deposition of a cartilaginous matrix fails shortly thereafter supports
the idea that Sox9 plays a very similar role in the development of the
otic capsule. Expression of Periostin in Sox9-deﬁcient mesenchymal
cells is compatible with the earlier notion that these cells differentiate
into non-otic ﬁbrocytes rather than into chondrocytes. Sox9 function
in otic capsule formation may be partly mediated by Tbx1, the
expression of which is strongly down-regulated in the outer
compartment of the Sox9-deﬁcient periotic mesenchyme at E12.5. In
support of these ﬁndings, inactivation of Tbx1 in the periotic
mesenchyme results in partial formation of the otic capsule, a defect
that was suggested to arise from reduced cell proliferation in the
periotic mesenchyme (Xu et al., 2007). However, pathways regulated
by Sox9 and Tbx1 are possibly different since Pou3f4 expression in the
periotic mesenchyme is only affected by loss of Tbx1 (Braunstein et al.,
2008; Braunstein et al., 2009) but not of Sox9.
Sox9 is required for differentiation and expansion of otic ﬁbrocytes
In addition to the arrest of chondrogenesis in the otic capsule,
development of otic ﬁbrocytes from the inner mesenchymal com-
partment was severely perturbed upon Sox9 inactivation in the
periotic mesenchyme. The number of ﬁbrocytes was reduced,
differentiation of lateral wall cell subtypes failed and perilymphatic
spaces were only partially established. Since Sox9 is transiently
expressed in precursors of otic ﬁbrocytes at early condensation stages
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requirement of Sox9 in this tissue. Indeed, we detected expression
changes of genes encoding ECM components including Col2a1 and
Col9a1 as early as E11.5 in the entire periotic mesenchyme.
Furthermore, cellular expansion of both mesenchymal compartments
was severely affected at E12.5 suggesting an early function of Sox9 in
regulating the proliferation of mesenchymal progenitors. Similarly,
Sox9 has been shown to control cell-autonomously proliferation to
maintain a progenitor cell pool during pancreas development
(Seymour et al., 2007). In Sox9-deﬁcient periotic mesenchyme,
proliferative defects may at least partly be caused by downregulation
of Tbx1 that is expressed in a similar pattern as Sox9 in the periotic
mesenchyme from E10.5 to E11.5 (Vitelli et al., 2003; Xu et al., 2007,
Figs. 1B and 6Q).
Alternatively, otic ﬁbrocyte development may not directly depend
on Sox9 function but may be inﬂuenced by signals from chondrogenic
mesenchymal precursors in the adjacent compartment. The speciﬁc
role of Sox9 in regulating the development of the inner compartment
of the periotic mesenchyme may be clariﬁed by conditional Sox9
inactivation in the periotic mesenchyme after E11.5 when Sox9 is no
longer expressed in precursors of otic ﬁbrocytes.
Sox9 is required for cochlear duct outgrowth and coiling morphogenesis
Growth and coiling morphogenesis of the cochlea rely on a precise
spatiotemporal coordination of cell proliferation and cellular rearran-
gements within the otic epithelium (Lang et al., 2000; McKenzie et al.,
2004; Kelly and Chen, 2007; for review see also Bok et al. (2007)). This
program is intrinsic to the epithelium but is also inﬂuenced by signals
from the surrounding mesenchyme (Miura et al., 2004).
A pioneering morphological study suggested that the otic capsule
constitutes a physical barrier that conﬁnes cochlear outgrowth and
thereby causes the coiling process (Li and McPhee, 1978; Li and
McPhee, 1979). However, the ﬁndings that inactivation of a number of
genes, e.g. Pou3f4 and Tbx1, from the pericochlear mesenchyme
disrupts cochlear morphogenesis (Phippard et al., 1999; Xu et al.,
2007) have recently highlighted the importance of signaling from the
otic mesenchyme to the cochlear epithelium. Our ﬁndings that the
loss of Sox9 in the periotic mesenchyme causes severe defects in the
morphogenesis of the cochlear duct, supports the notion that cochlear
coiling is not simply the result of physical constraints imposed by a
cartilaginous template but relies on the co-ordinated interaction
between the epithelial and mesenchymal compartments of the
cochlea throughout development. Alterations in epithelial prolifera-
tion, thickening of the otic epithelium and increase of cochlear duct
diameter in Sox9KO embryos at E12.5, demonstrate the necessity of
mesenchymal signals for epithelial morphogenesis already at pre-
cartilagenous stages. Therefore, Sox9 may directly regulate these
signals for cochlear duct outgrowth at this stage.
At present, the molecular identity of these mesenchymal factors is
unknown. Our study excluded a number of signaling pathways known
in tissue interactions including Wnt/ß-Catenin, Fgf, Bmp, TgFß,
retinoic acid and Hedgehog to act downstream of Sox9 in the otic
mesenchyme in the control of cochlear morphogenesis. In addition to
secreted proteins, ECM components including collagens may control
cochlear outgrowth. Collagens provide integrity and elasticity to
developing tissues, mediate cell adhesion and epithelial morphogen-
esis (for reviews see Heino (2007) and Rozario and Desimone (2009))
and constitute central components of the ECM of the developing
periotic mesenchyme and its derivatives (Van De Water and
Galinovic-Schwartz, 1987; Berggren et al., 1997; Shpargel et al.,
2004; Asamura et al., 2005). In particular, Collagen II deposition is
remarkably increased during periotic mesenchyme condensation at
E12.5 (D'Amico-Martel et al., 1987) and disruption of its spatiotem-
poral distribution pattern alters morphogenesis of the inner ear (Van
DeWater and Galinovic-Schwartz, 1987). Sox9 is a known regulator ofECM composition, by directly activating the transcription of Col genes
such as Col2a1, Col4a2 and Col9a1 (Bell et al., 1997; Zhang et al., 2003;
Genzer and Bridgewater, 2007; Sumi et al., 2007). Reduced expression
of Col2a1 and Col9a1 in the periotic mesenchyme at E12.5 in the Sox9
mutant suggests that aberrant coiling morphogenesis is at least
partially due to a loss of Sox9 function in modulating the composition
of the ECM of the periotic mesenchyme. The ECM is critically involved
in mediating the transport, storage, degradation and binding of
growth factors to respective receptors (for reviews see Rozario and
Desimone (2009) and Tsang et al. (2010)). Interestingly, the adjacent
hindbrain has been identiﬁed as an important source for growth
factors such as Sonic hedgehog (Shh),Wnt1, andWnt3a that inﬂuence
the development of the otic epithelium in mice (Riccomagno et al.,
2002; Riccomagno et al., 2005; also reviewed in Bok et al. (2007) and
Schneider-Maunoury and Pujades (2007)). A series of tissue trans-
plantation experiments in chicken embryos also suggested the
existence of rhombomere speciﬁc, yet unidentiﬁed, signaling factors
that are required for cochlear growth andmorphogenesis (Liang et al.,
2010). It is therefore possible that the phenotypes observed in the
Sox9KO mutant reﬂect the consequence of an aberrant communica-
tion between the hindbrain and the otic epithelium.
The mild gene expression changes in the cochlear epithelium of
Sox9KO mutants, strongly argue that major patterning events of the
otic vesicle and the early cochlear duct occur independently from Sox9
(-dependent processes) in the surrounding mesenchyme. Fine-
tuning, in contrast, may occur later upon interaction with the periotic
mesenchyme. Aberrant differentiation of sensory cells, as reported for
mesenchyme-speciﬁc Tbx1KOmice (Xu et al., 2007), was not detected
in Sox9KO mutants. This suggests that mesenchymal Tbx1 expression
controls signaling pathways that establish or maintain the sensory
epithelium independent from Sox9 in the early periotic mesenchyme,
and excludes a major role for the otic capsule and otic ﬁbrocytes in
epithelial differentiation.
In conclusion, this study demonstrates that Sox9 is an essential
regulator of differentiation and expansion of otic ﬁbrocytes, formation
of the otic capsule and cochlear duct coiling and provides a new
mouse model to demonstrate the intimate interaction of mesenchy-
mal and epithelial compartments during the development of the inner
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